Chris Klee
Board Observer
Pharmacy
Magenta Therapeutics, Inc.
Norway
Biography
Mr. Chris Klee serves as is the Chief Financial Officer for Novartis US. Mr. Klee served in a dual capacity as Chief Operating Officer for Novartis Institutes for BioMedical Research (NIBR) and Country Chief Financial Officer for Novartis US. He originally joined Novartis as a Business Planning Analyst and held a number of increasingly senior positions in the Pharma division. In 2005, he joined NIBR as Chief Financial Officer and later assumed an expanded role as Chief Operating Officer. He has been Board Observer at Magenta Therapeutics, Inc. since October 24, 2017. He graduated from the Business School of the University of St. Gallen with a degree in finance and economics.
Research Interest
Pharmacy
